BRPI0918431A2 - produto farmacêutico compreendendo um antagonista de receptor muscarínico e um agonista de beta-2-adrenoceptor. - Google Patents
produto farmacêutico compreendendo um antagonista de receptor muscarínico e um agonista de beta-2-adrenoceptor.Info
- Publication number
- BRPI0918431A2 BRPI0918431A2 BRPI0918431A BRPI0918431A BRPI0918431A2 BR PI0918431 A2 BRPI0918431 A2 BR PI0918431A2 BR PI0918431 A BRPI0918431 A BR PI0918431A BR PI0918431 A BRPI0918431 A BR PI0918431A BR PI0918431 A2 BRPI0918431 A2 BR PI0918431A2
- Authority
- BR
- Brazil
- Prior art keywords
- beta
- receptor antagonist
- pharmaceutical product
- muscarinic receptor
- adrenoceptor agonist
- Prior art date
Links
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 title 1
- 239000000048 adrenergic agonist Substances 0.000 title 1
- 102000014974 beta2-adrenergic receptor activity proteins Human genes 0.000 title 1
- 108040006828 beta2-adrenergic receptor activity proteins Proteins 0.000 title 1
- 239000003149 muscarinic antagonist Substances 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 229940127557 pharmaceutical product Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0814728.2A GB0814728D0 (en) | 2008-08-12 | 2008-08-12 | New combination |
| PCT/SE2009/050925 WO2010019098A1 (en) | 2008-08-12 | 2009-08-11 | Pharmaceutical product comprising a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0918431A2 true BRPI0918431A2 (pt) | 2015-11-24 |
Family
ID=39790659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0918431A BRPI0918431A2 (pt) | 2008-08-12 | 2009-08-11 | produto farmacêutico compreendendo um antagonista de receptor muscarínico e um agonista de beta-2-adrenoceptor. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20110245293A1 (pt) |
| EP (1) | EP2323656A4 (pt) |
| JP (1) | JP2011530587A (pt) |
| KR (1) | KR20110045051A (pt) |
| CN (1) | CN102202664A (pt) |
| AU (1) | AU2009282520A1 (pt) |
| BR (1) | BRPI0918431A2 (pt) |
| CA (1) | CA2733523A1 (pt) |
| GB (1) | GB0814728D0 (pt) |
| MX (1) | MX2011001579A (pt) |
| RU (1) | RU2011105463A (pt) |
| WO (1) | WO2010019098A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200825084A (en) | 2006-11-14 | 2008-06-16 | Astrazeneca Ab | New compounds 521 |
| US8329729B2 (en) | 2008-05-13 | 2012-12-11 | Astrazeneca Ab | Quinuclidine derivatives as muscarinic M3 receptor antagonists |
| MX2011001577A (es) * | 2008-08-12 | 2011-05-02 | Pulmagen Therapeutics Synergy | Sal de 2-hidroxi-etansulfonato. |
| JO3192B1 (ar) | 2011-09-06 | 2018-03-08 | Novartis Ag | مركب بنزوثيازولون |
| WO2016009253A1 (en) * | 2014-07-16 | 2016-01-21 | Anil Mishra | Recombinant interleukin-15 is a therapeutic agent for the treatment of airway hyperactivity, resistance (obstruction) and fibrosis in chronic asthma |
| CN117500497A (zh) * | 2021-04-16 | 2024-02-02 | Ads医疗有限责任公司 | 与毒蕈碱激动剂药偶联的α2肾上腺素能激动剂复合药 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2204295B1 (es) * | 2002-07-02 | 2005-08-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de quinuclidina-amida. |
| RU2385156C2 (ru) * | 2004-05-31 | 2010-03-27 | Лабораториос Альмираль С.А. | Комбинации, содержащие антимускариновые средства и кортикостероиды |
| TW200738658A (en) * | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
| TW200738659A (en) * | 2005-08-29 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
| WO2008023157A1 (en) * | 2006-08-21 | 2008-02-28 | Argenta Discovery Limited | Nitrogen containing heterocyclic compounds useful as m3-receptor modulators |
| TW200833670A (en) * | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
| GB0702385D0 (en) * | 2007-02-07 | 2007-03-21 | Argenta Discovery Ltd | New combination |
| US20100056565A1 (en) * | 2007-02-15 | 2010-03-04 | Argenta Discovery Limited | Heterocyclic Derivatives as M3 Muscarinic Receptors |
-
2008
- 2008-08-12 GB GBGB0814728.2A patent/GB0814728D0/en not_active Ceased
-
2009
- 2009-08-11 BR BRPI0918431A patent/BRPI0918431A2/pt not_active Application Discontinuation
- 2009-08-11 AU AU2009282520A patent/AU2009282520A1/en not_active Abandoned
- 2009-08-11 MX MX2011001579A patent/MX2011001579A/es unknown
- 2009-08-11 RU RU2011105463/15A patent/RU2011105463A/ru not_active Application Discontinuation
- 2009-08-11 CA CA2733523A patent/CA2733523A1/en not_active Abandoned
- 2009-08-11 KR KR1020117005789A patent/KR20110045051A/ko not_active Withdrawn
- 2009-08-11 US US13/058,781 patent/US20110245293A1/en not_active Abandoned
- 2009-08-11 EP EP09806920A patent/EP2323656A4/en not_active Withdrawn
- 2009-08-11 JP JP2011522935A patent/JP2011530587A/ja active Pending
- 2009-08-11 CN CN2009801403219A patent/CN102202664A/zh active Pending
- 2009-08-11 WO PCT/SE2009/050925 patent/WO2010019098A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2323656A1 (en) | 2011-05-25 |
| WO2010019098A1 (en) | 2010-02-18 |
| US20110245293A1 (en) | 2011-10-06 |
| GB0814728D0 (en) | 2008-09-17 |
| AU2009282520A1 (en) | 2010-02-18 |
| CN102202664A (zh) | 2011-09-28 |
| EP2323656A4 (en) | 2012-05-30 |
| MX2011001579A (es) | 2011-04-27 |
| CA2733523A1 (en) | 2010-02-18 |
| RU2011105463A (ru) | 2012-09-20 |
| JP2011530587A (ja) | 2011-12-22 |
| KR20110045051A (ko) | 2011-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC2379069I2 (lt) | S1p receptoriaus agonisto dozavimas | |
| BRPI0919539A2 (pt) | antagonistas de receptor de opioide periférico e empregos dos mesmos | |
| PT2317852E (pt) | Formulações farmacêuticas contendo ligandos de recetor de dopamina | |
| DK2692341T3 (da) | Misbrugs-resistent lægemiddelformulering | |
| DK2252581T3 (da) | Kappa-selektiv opioidreceptorantagonist | |
| BRPI1014877A8 (pt) | compostos diamida tendo antagonista do receptor muscarínico e atividade agonista do receptor b2 adrenérgico. | |
| BRPI0821683A2 (pt) | Medicamento compreendendo um agonista parassimpatético e um antagonista simpatético ou agonista simpatético | |
| DK2274030T4 (da) | Lægemiddelafgivelsesanordning | |
| BRPI0913008A2 (pt) | dispositivo de administração de medicação | |
| EP2350060A4 (en) | Melanocortin receptor AGONISTS | |
| BRPI0910118A2 (pt) | antagonistas de receptores do glucagon | |
| DK2381986T3 (da) | Lægemiddeladministrationsanordning | |
| ATE509022T1 (de) | Nikotin-acetylcholin-rezeptorsubtyp-selektive diazabicycloalkanamide | |
| BRPI0810926A2 (pt) | Antagonista de crig | |
| BRPI0820805A2 (pt) | Antagonista do receptor de mineralocorticóides derivados da 6h-di-benzo[b,e]oxepina | |
| PL2379086T3 (pl) | Preparat farmeceutyczny | |
| BRPI0806966A2 (pt) | Combinação de um antagonista de receptor muscarínico e um agonista beta-2-adrenoceptor | |
| BRPI0817833A2 (pt) | Composição farmacêutica antimalárica | |
| IL198780A0 (en) | Pharmaceutical formulation comprising neurokinin antagonist | |
| BRPI0922423A2 (pt) | dispositivo de liberação de fármaco | |
| BR112012002445A2 (pt) | uso de um agonista do receptor 4 de melanocortina. | |
| BRPI0912657A2 (pt) | produto farmacêutico compreendendo um antagonista de receptor muscarínico e um agonista beta2-adrenorreceptor | |
| BRPI0912656A2 (pt) | formulação farmacêutica sólida | |
| DK2257534T3 (da) | 3-aminoalkyl-1,4-diazepan-2-on-melanocortin-5-receptorantagonister | |
| BRPI0908075A2 (pt) | Antagonísta muscarínicos de pde4-duplos farmacóforos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |